Pelthos Therapeutics (PTHS) Long-Term Deferred Tax (2022 - 2024)
Pelthos Therapeutics (PTHS) posted quarterly Long-Term Deferred Tax of $5.6 million for Q4 2024, up 15346.16% year-over-year from N/an in Q1 2024, and up 15346.16% quarter-over-quarter from $36202.0 in Q4 2023.
Pelthos Therapeutics (PTHS) Long-Term Deferred Tax (2022 - 2024) Analysis & Trends
Pelthos Therapeutics' Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $5.6 million for Q4 2024.
- In Q4 2024, Long-Term Deferred Tax rose 15346.16% year-over-year to $5.6 million; the TTM figure through Dec 2024 stood at $5.6 million (up 15346.16% YoY), while the FY2024 annual figure was $5.6 million, up 15346.16% from the prior year.
- Long-Term Deferred Tax for Q4 2024 stood at $5.6 million, up from $36202.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $5.6 million in Q4 2024, with the low at $36202.0 in Q4 2023.
- The 3-year median for Long-Term Deferred Tax is $1.9 million (2022), against an average of $2.5 million.
- The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax slumped 98.05% in 2023, then soared 15346.16% in 2024.
- Pelthos Therapeutics' Long-Term Deferred Tax stood at $1.9 million in 2022, then plunged by 98.05% to $36202.0 in 2023, then jumped by 15346.16% to $5.6 million in 2024.
- Business Quant data shows PTHS's Long-Term Deferred Tax at $5.6 million in Q4 2024, $36202.0 in Q4 2023, and $1.9 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pelthos Therapeutics | 91.09 Mn | 66.53 Mn | 21.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.59 Mn |
| Dec 31, 2023 | 36,202.00 |
| Dec 31, 2022 | 1.86 Mn |